Market cap
₹129 Cr
Recently Viewed
Clear AllNSE: INVICTA
₹102.75
₹5.40
(5.55%)
As on 29-Apr-2026IST
Market cap
₹129 Cr
Revenue (TTM)
₹30 Cr
P/E Ratio
26.4
P/B Ratio
3
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹5 Cr
ROE
40.5 %
ROCE
42.9 %
Industry P/E
53.11
EV/EBITDA
14.1
Debt to Equity
0.2
Book Value
₹17.4
EPS
₹5.8
Face value
10
Shares outstanding
12,571,973
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Invicta Diagnostic
| 29.6 | 58.1 | 63.1 | -- | -- | -- | -- |
|
BSE Healthcare
| 2.8 | 5.2 | 8.2 | 4.9 | 24.7 | 13.9 | 11.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Invicta Diagnostic
|
102.8 | 129.2 | 30.1 | 4.9 | -- | 40.5 | 26.4 | 3.0 |
| 1,397.8 | 23,415.8 | 2,662.8 | 533.1 | 22.9 | 24.1 | 44.3 | 9.1 | |
| 665.3 | 26,623.2 | 3,626.9 | 315.0 | 15.0 | 13.3 | 88.5 | 11.5 | |
| 581.0 | 1,881.8 | 766.3 | 80.5 | 15.7 | 8.9 | 23.4 | 2.0 | |
| 478.8 | 9,933.1 | 1,566.5 | 169.5 | 14.8 | 12.7 | 59 | 6.6 | |
| 531.8 | 5,325.6 | 755.8 | 67.1 | -- | 13.8 | 79.4 | 5.5 | |
| 282.6 | 895.6 | 1,231.3 | 29.1 | -4.7 | 4 | 34.4 | 1.3 | |
| 280.8 | 1,468.9 | 294.1 | 32.4 | 17.4 | 15.1 | 44.1 | 6.2 | |
| 404.4 | 6,431.1 | 792.3 | 135.5 | 23.5 | 26.4 | 46.7 | 9.6 | |
| 1,114.1 | 10,760.2 | 768.1 | 159.9 | 29.2 | 19.3 | 67.5 | 11.9 |
No Review & Analysis are available.
--
Incorporated
2023
Chairman
Sanket Vinod Jain
Managing Director
--
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Invicta Diagnostic Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Invicta Diagnostic Ltd is ₹102.75 (NSE) as of 29-Apr-2026 IST. Invicta Diagnostic Ltd has given a return of --% in the last 1 years.
The P/E ratio of Invicta Diagnostic Ltd is 26.41 times as on 29-Apr-2026, a 50 discount to its peers’ median range of 53.11 times.
The P/B ratio of Invicta Diagnostic Ltd is 2.96 times as on 29-Apr-2026, a 60 discount to its peers’ median range of 7.31 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
The 52-week high and low of Invicta Diagnostic Ltd are Rs 105.00 and Rs 58.10 as of 29-Apr-2026.
Invicta Diagnostic Ltd has a market capitalisation of ₹ 129 Cr as on 29-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Invicta Diagnostic Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.